Fig. 8.
Fig. 8. Effect of RGD peptide on endothelial CD31-induced enhancement of eosinophil adhesion to IL-4–stimulated vascular endothelial cells. IL-4–stimulated HUVECs were preincubated with anti-CD31 MoAb or control mouse IgG (10 μg/mL each) for 10 minutes at 37°C. After washing HUVECs, the adhesion assay of51Cr-labeled eosinophils to HUVECs was performed in the presence of GRGDSP peptide (▪) or GRGESP peptide (control peptide; ▨; 5, 50, and 500 μg/mL each). Data are the means ± SD for 4 experiments. *Significantly different from the mean value of the control response (*P < .005). **Significantly different from the mean value of the control response of anti-CD31 MoAb-pretreated HUVECs (**P < .005).

Effect of RGD peptide on endothelial CD31-induced enhancement of eosinophil adhesion to IL-4–stimulated vascular endothelial cells. IL-4–stimulated HUVECs were preincubated with anti-CD31 MoAb or control mouse IgG (10 μg/mL each) for 10 minutes at 37°C. After washing HUVECs, the adhesion assay of51Cr-labeled eosinophils to HUVECs was performed in the presence of GRGDSP peptide (▪) or GRGESP peptide (control peptide; ▨; 5, 50, and 500 μg/mL each). Data are the means ± SD for 4 experiments. *Significantly different from the mean value of the control response (*P < .005). **Significantly different from the mean value of the control response of anti-CD31 MoAb-pretreated HUVECs (**P < .005).

Close Modal

or Create an Account

Close Modal
Close Modal